X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/866145/bausch-health-canada-inc-announces-additional-public-drug-plan-listings-for-pruceris-budesonide-aerosol-foam-to-treat-mild-to-moderate-distal-ulcerative-colitis-in-adults
https://www.accesswire.com/863397/bausch-health-announces-2024-annual-meeting-of-shareholder-results
https://www.accesswire.com/863259/bausch-health-announces-updates-related-to-norwich-xifaxan-matters
https://www.accesswire.com/858606/bausch-health-announces-first-quarter-2024-results
https://www.accesswire.com/852372/bausch-health-to-announce-first-quarter-2024-results-on-may-2
https://www.accesswire.com/852453/court-of-appeals-for-the-federal-circuit-issues-ruling-in-norwich-case-that-prevents-fda-approval-of-norwichs-abbreviated-new-drug-application-until-2029
https://www.accesswire.com/852150/acne-vulgaris-treatment-prarazlo-tazarotene-lotion-0045-now-available-to-patients-through-british-columbia-pharmacare-public-drug-plan
https://www.accesswire.com/850631/bausch-health-announces-patent-lawsuit-against-amneal-pharmaceuticals
Market Place
Share 
